Table 1 Characteristics of the study population
From: Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
Characteristics | Control (N = 10) | UC (N = 7) | p Value |
|---|---|---|---|
Male/female (%) | 5/5(50/50) | 3/4(43/57) | p > 0.05 |
Median (IQR) age (years) | 47(31–50.5) | 47(31–50.5) | p > 0.05 |
Median (IQR) duration of disease (years) | NA | 5(2–6.5) | NA |
Median (IQR) BMI | 25(23–26.5) | 26(21–27) | p > 0.05 |
Medication | NA | Â | NA |
5-Aminosalicylic acid (%) | Â | 7(100) | Â |
Azathioprine (%) | Â | 4(57) | Â |
Corticosteroids (%) | Â | 2(29) | Â |
Anti-TNF (%) | Â | 1(19) | Â |
Disease activity | NA | Â | NA |
Remission (SCCAI Score < 5) | Â | 3(43) | Â |
Active (SCCAI Score ≥ 5) |  | 4(57) |  |